Literature DB >> 27262256

Pathophysiology of Type 2 Diabetes: The Evolution of Our Understanding.

Stephen Brunton1.   

Abstract

This review article explores scientists' current understanding of type 2 diabetes as a complex disorder that involves not just the pancreas and insulin system but also the liver, kidneys, gut, muscle, fat cells, and even the brain. An appreciation of the complex pathophysiology of type 2 diabetes allows the primary care practitioner to best manage patients with this common and serious disorder.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27262256

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  11 in total

1.  Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes.

Authors:  John E Anderson
Journal:  Diabetes Spectr       Date:  2020-05

2.  Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes.

Authors:  Yali Zhang; Rong Shi; Liang Yu; Liping Ji; Min Li; Fan Hu
Journal:  Diabetes Ther       Date:  2020-07-28       Impact factor: 2.945

3.  Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes.

Authors:  Tri Juli Edi Tarigan; Adisti Dwijayanti; Susie Setyowati; Melva Louisa
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-12       Impact factor: 3.168

4.  Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational studies.

Authors:  Manuela Neuenschwander; Janett Barbaresko; Claudia R Pischke; Nadine Iser; Julia Beckhaus; Lukas Schwingshackl; Sabrina Schlesinger
Journal:  PLoS Med       Date:  2020-12-02       Impact factor: 11.069

5.  Understanding the bigger picture: syndemic interactions of the immigrant and refugee context with the lived experience of diabetes and obesity.

Authors:  Nicole Naadu Ofosu; Thea Luig; Yvonne Chiu; Naureen Mumtaz; Roseanne O Yeung; Karen K Lee; Nancy Wang; Nasreen Omar; Lydia Yip; Sarah Aleba; Kiki Maragang; Mulki Ali; Irene Dormitorio; Denise Campbell-Scherer
Journal:  BMC Public Health       Date:  2022-02-18       Impact factor: 3.295

6.  Functional annotation and enrichment analysis of differentially expressed serum proteins in patients with type 2 diabetes after dapagliflozin.

Authors:  Yan-Xue Zhao; Sarul Borjigin; Zhao-Li Yan
Journal:  World J Diabetes       Date:  2022-03-15

7.  Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection.

Authors:  Herdiantri Sufriyana; Hotimah Masdan Salim; Akbar Reza Muhammad; Yu-Wei Wu; Emily Chia-Yu Su
Journal:  Comput Struct Biotechnol J       Date:  2022-08-08       Impact factor: 6.155

8.  Wingless-type MMTV integration site family member 5a: a novel biomarker regulated in type 2 diabetes mellitus and diabetic kidney disease.

Authors:  Wei Xu; Houfa Geng; Xuekui Liu; Xiuli Wang; Rui Li; Qian Lv; Yin Liu; Jie Wang; Manqing Yang; Peter M Jones; Jun Liang
Journal:  J Diabetes Metab Disord       Date:  2019-11-22

9.  Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction.

Authors:  You Yu; Lin Wang; Xu Zhu; Ya-Fei Liu; Hai-Ying Ma
Journal:  World J Diabetes       Date:  2021-12-15

10.  Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes.

Authors:  Jonathan Uriel Quevedo-Martínez; Yonathan Garfias; Joanna Jimenez; Osvaldo Garcia; Diana Venegas; Victor Manuel Bautista de Lucio
Journal:  BMJ Open Ophthalmol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.